Sen-Jam Pharmaceutical Email Format

Biotechnology ResearchNew York, United States11-50 Employees

Sen-Jam Pharmaceutical is a biotechnology research company based in Huntington, New York. It focuses on anti-inflammatory therapies developed by repurposing existing molecules into novel combination regimens. The firm holds a multi-indication patent and has a product candidate that is FDA-pending, targeting prevention of pain and flu-like symptoms in indications not covered by the FDA OTC Drug Monograph.

The company has pursued partnerships to advance its development, including a 2024 collaboration with Mallinckrodt to provide formulation and chemistry, manufacturing, and controls for an anti-inflammatory injectable. In 2025, it announced the addition of Dr. Ashley St. John to its Scientific Advisory Board, bringing immunology and infectious disease expertise. The organization operates with a small to mid-sized team focused on advancing its portfolio within the biotechnology research sector.

Get verified Sen-Jam Pharmaceutical emails free

Company overview Employee directory